Chankana Biotech

Chankana Biotech is a biotechnology company focused on developing novel therapeutics for chronic Hepatitis B and associated liver diseases. The company's primary research centers on targeting the Hepatitis B virus X protein (HBx), which plays a critical role in viral replication and the development of hepatocellular carcinoma. By leveraging natural product-derived small molecules, Chankana aims to provide curative treatments that address the limitations of current standard-of-care therapies. Their lead programs are currently in the pre-clinical stage, with a focus on disrupting the viral lifecycle and preventing disease progression.